PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis.

Beck, Laurence H; Berasi, Stephen P; Copley, J Brian; Gorman, Donal; Levy, Daniel I; Lim, Chay Ngee; Henderson, Joel M; Salant, David J; Lu, Weining.

Afiliação

Beck LH; Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Berasi SP; Pfizer Inc., Cambridge, Massachusetts, USA.
Copley JB; Pfizer Inc., Cambridge, Massachusetts, USA.
Gorman D; Pfizer Inc., Cambridge, United Kingdom.
Levy DI; Pfizer Inc., Cambridge, Massachusetts, USA.
Lim CN; Pfizer Inc., Cambridge, Massachusetts, USA.
Henderson JM; Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Salant DJ; Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Lu W; Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.